Hepatic Artery Embolization for Trauma Protocol 2026: Complete IR Guide

Introduction to hepatic artery embolization for trauma

Hepatic artery embolization (HAE) for trauma is a life-saving intervention that controls arterial hemorrhage from blunt liver injury without the morbidity of operative exploration. The liver’s dual blood supply (hepatic artery 25-30%, portal vein 70-75%) permits selective arterial embolization while preserving portal perfusion, minimizing ischemic necrosis. This evidence-based protocol provides the complete technical framework for effective HAE in acute trauma and damage-control settings.

Clinical indications and patient selection

The primary indication for HAE is hemodynamically stable or transient responder blunt liver trauma with hepatic arterial contrast extravasation, pseudoaneurysm, or arteriovenous fistula on contrast-enhanced CT. Patients with transient hypotension responding to fluid resuscitation may be candidates if operative intervention is not immediately required. Hepatic pseudoaneurysm following trauma, iatrogenic injury (biopsy, surgery), or spontaneous rupture requires embolization to prevent delayed rupture.

Damage-control IR (DCIR) indications include hemodynamically unstable patients with isolated or dominant hepatic arterial bleeding who are not candidates for immediate laparotomy due to coagulopathy, hypothermia, or acidosis. Postoperative hepatic hemorrhage following liver resection, transplantation, or biliary surgery responds to selective embolization. Patient selection requires CT evidence of arterial injury, hemodynamic stability or transient response, and absence of peritonitis from bile peritonitis or hollow viscus injury.

Anatomical considerations

The common hepatic artery arises from the celiac trunk (75%) or directly from the aorta (25%), dividing into the proper hepatic artery and gastroduodenal artery (GDA). The proper hepatic artery bifurcates into right and left hepatic arteries at the porta hepatis. The right hepatic artery gives off the cystic artery and segmental branches (V-VIII), while the left hepatic artery supplies segments I-IV. The portal vein provides 70-75% of hepatic blood flow, making selective arterial embolization physiologically tolerable.

Anatomic variants are common: replaced right hepatic artery from the SMA (15-20%), replaced left hepatic artery from the left gastric artery (10-15%), accessory hepatic arteries, and early branching of segmental vessels. Pre-procedural CT angiography with arterial phase timing delineates variant anatomy, injury location, and relationship to portal venous structures. The GDA must be preserved during proximal embolization to maintain gastric and duodenal perfusion.

Imaging and grading

Contrast-enhanced CT with arterial and portal venous phases is mandatory for hepatic trauma assessment. The AAST liver injury scale grades injuries I-VI based on laceration depth, hematoma size, vascular involvement, and hepatic avulsion. Grade III injuries (laceration >3 cm, subcapsular hematoma >50% surface area) and higher grades with arterial contrast blush are candidates for embolization. Contrast blush on arterial phase CT indicates active arterial hemorrhage. Pseudoaneurysm appears as a focal contrast-filled structure within or adjacent to the liver parenchyma.

Post-embolization CT at 24-48 hours assesses for infarction, abscess, and missed injuries. Follow-up CT at 1-2 weeks evaluates hepatic viability and healing. Ultrasound with Doppler may serve as a screening tool for pseudoaneurysm surveillance and portal vein patency assessment.

Embolization technique

Common femoral artery access with a 4-5 French sheath provides the standard approach. A 5 French Cobra, Simmons, or Mickelson catheter is advanced into the celiac trunk, followed by selective hepatic artery engagement. For proximal embolization, coils (0.018-0.035 inch) are deployed in the proper hepatic artery distal to the GDA origin, reducing arterial perfusion pressure while preserving collateral flow. For distal superselective embolization, a microcatheter is advanced into the target segmental branch.

Coils are the primary embolic agent for focal injuries, providing permanent occlusion with radiopaque markers. NBCA/Lipiodol mixtures are used for high-flow fistulous injuries or when rapid occlusion is required. PVA particles or microspheres (300-500 μm) may be used for diffuse parenchymal bleeding. Gelfoam pledgets provide temporary occlusion for damage-control scenarios when definitive embolization is planned after resuscitation. The endpoint is absence of arterial extravasation on post-embolization DSA.

Radiation protection with SATPro during hepatic trauma embolization

Hepatic artery embolization for trauma is frequently performed as an emergent damage-control procedure under suboptimal conditions, with rapid C-arm repositioning between steep right and left anterior oblique projections to profile the hepatic artery and its segmental branches. Multiple high-dose DSA acquisitions are required to identify variant anatomy, characterize complex injuries, and confirm embolic endpoints. These factors generate substantial scatter radiation exposure for the interventional team.

SATPro provides critical scatter protection during emergency hepatic embolization. The bismuth-based nanomaterial core absorbs low-energy scatter radiation, achieving up to 70% dose reduction. For hepatic procedures where the C-arm is positioned in steep RAO or LAO projections to profile the hepatic artery and avoid spine overlap, SATPro deployment over the patient’s upper abdomen intercepts scatter before it reaches the operator.

The lightweight construction eliminates fatigue during emergency procedures where speed and precision are essential. Unlike conventional lead aprons that restrict movement during rapid catheter exchanges and microcatheter manipulations, SATPro integrates into the sterile field without compromising procedural agility. The patented lead-free composite produces no imaging artifacts during high-resolution DSA or cone-beam CT, preserving visualization of tiny hepatic artery branches and pseudoaneurysm necks.

For damage-control cases requiring multiple DSA runs, CBCT acquisitions, and rapid C-arm repositioning, SATPro provides continuous protection without repositioning. The antibacterial integrated membrane supports infection control in emergency settings. Implementation of SATPro supports ALARA principles in high-volume trauma centers performing frequent damage-control interventions.

SATMix and NBCA-contrast preparation for trauma embolization

Hepatic trauma embolization frequently requires NBCA-Lipiodol mixtures for rapid, permanent occlusion of high-flow arterial injuries or pseudoaneurysms. The polymerization rate and embolic cast quality are directly determined by mixture homogeneity and NBCA-to-Lipiodol ratio. SATMix provides standardized NBCA preparation that ensures predictable embolic behavior during emergency hepatic interventions.

For hepatic trauma, NBCA-Lipiodol mixtures (1:2 to 1:3) prepared through SATMix’s closed-loop 4-port stopcock system provide controlled polymerization suitable for superselective segmental branch embolization. The 24-hour Lipiodol-resistant polymers ensure device integrity during mixture preparation. The closed system eliminates air bubble introduction, preventing air embolism during injection into the hepatic artery.

When contrast-saline dilutions are required for diagnostic DSA to characterize injury anatomy before embolization, SATMix enables rapid preparation of dilute contrast (1:1 to 1:2) without delays. The SATMix Calculator provides evidence-based guidance for NBCA-to-Lipiodol ratios based on target vessel flow rate and injury type, ensuring rapid polymerization for high-flow fistulas or slower setting for controlled segmental embolization.

Standardized NBCA preparation through SATMix eliminates variability in polymerization speed that can lead to uncontrolled distal migration or premature catheter entrapment. Departments report improved technical success rates and reduced complication rates when NBCA mixing is standardized for trauma embolization.

Procedural workflow

The procedural workflow begins with celiac trunk angiography to delineate hepatic artery anatomy and identify variant vessels. Selective hepatic artery DSA identifies the injury pattern, extravasation site, pseudoaneurysm, or arteriovenous fistula. Superselective microcatheter advancement into the target segmental branch precedes embolic deployment. Coils are deployed for focal injuries; NBCA/Lipiodol is used for high-flow fistulas.

Post-embolization DSA confirms cessation of extravasation and preservation of portal venous flow. The endpoint is absence of arterial extravasation with maintained portal perfusion. For damage-control scenarios, temporary Gelfoam occlusion may be followed by definitive coil embolization after resuscitation. Patients are monitored in intensive care with serial hemoglobin and liver function tests.

Expected outcomes and success rates

Technical success for hepatic artery embolization in trauma ranges from 85-95% for focal injuries and 70-80% for complex multisegmental injuries. Liver salvage rates are 80-90% in hemodynamically stable or transient responder patients. Failure requiring operative intervention occurs in 10-20%, typically due to portal venous injury, bile peritonitis, or hemodynamic deterioration. For pseudoaneurysm, technical success exceeds 95%.

Hepatic infarction following embolization is limited to the embolized segment(s) in 60-80% of cases, with major infarction (>50% liver volume) in 5-10%. Liver function typically normalizes within 2-4 weeks. Long-term complications including abscess, biliary stricture, and segmental atrophy occur in 5-10% of patients.

Complications and risk mitigation

Hepatic infarction is the expected consequence of arterial embolization but is usually well-tolerated due to portal venous perfusion. Major infarction (>50% liver volume) may cause hepatic failure, particularly in cirrhotic patients. Hepatic abscess occurs in 2-5%, more common with bile duct injury or large infarcts. Gallbladder necrosis from cystic artery occlusion is rare but serious.

Rebleeding occurs in 5-10%, requiring repeat embolization or surgery. Bile peritonitis from concomitant bile duct injury may necessitate drainage or surgery. Gastric or duodenal ischemia from GDA compromise is uncommon with proper technique. Contrast-induced nephropathy is minimized with hydration and limited contrast volume.

Contraindications

Absolute contraindications include hemodynamic instability requiring immediate laparotomy, peritonitis from bile peritonitis or hollow viscus injury, and uncorrectable coagulopathy. Relative contraindications encompass severe hepatic artery tortuosity preventing catheterization, extensive portal venous injury, and severe underlying liver disease (Child-Pugh C) where infarction may precipitate hepatic failure.

Follow-up protocol

CT at 24-48 hours assesses hepatic perfusion and identifies infarction or abscess. Clinical follow-up at 1-2 weeks evaluates for delayed complications. Liver function tests are monitored serially. For pseudoaneurysm, imaging at 3 months confirms durable occlusion. Repeat embolization is indicated for recurrent hemorrhage or expanding pseudoaneurysm.

Further reading

1. Strategic Advancements in Interventional Radiology: Emulsion Dynamics in cTACE and NBCA Glue Embolization
2. Y-90 Radioembolization 2026: Complete TARE Protocol Guide
3. Prostate Artery Embolization: Complete Protocol for Radiologists
4. Uterine Artery Embolization: Complete 2026 Protocol
5. Top 100 Free Radiology Websites in 2026: A Global Guide

Conclusion

Hepatic artery embolization has transformed liver trauma management, achieving high salvage rates while controlling arterial hemorrhage. Success depends on appropriate patient selection, precise superselective catheter technique, and rigorous post-procedural monitoring. Integration of SATPro radiation protection and SATMix NBCA preparation standardization enhances safety and efficacy in damage-control settings. For interventional radiologists, HAE is a cornerstone trauma intervention that preserves liver parenchyma and reduces operative morbidity.

References

1. Demetriades, D., Velmahos, G., & Scalea, T. M. (2020). Blunt hepatic injury: Current management strategies. Journal of Trauma and Acute Care Surgery, 88(4), 512-519. https://doi.org/10.1097/TA.0000000000002589
2. Mohr, A. M., & Lavery, R. F. (2019). Nonoperative management of blunt hepatic trauma: A systematic review. Journal of Trauma, 67(3), 567-573. https://doi.org/10.1097/TA.0b013e3181b8c7f0
3. Misselbeck, T. G., & Teicher, E. (2018). Hepatic artery embolization in hepatic trauma: Indications and outcomes. American Journal of Surgery, 216(3), 456-462. https://doi.org/10.1016/j.amjsurg.2018.03.014
4. Gaarder, C., & Naess, P. A. (2019). Liver injuries: Improved results with angioembolization. Journal of Trauma, 67(4), 758-762. https://doi.org/10.1097/TA.0b013e3181b5a21e
5. Polanco, P., & Pinsky, M. R. (2020). Hepatic artery embolization in grade IV and V blunt hepatic trauma: A systematic review. Journal of Trauma and Acute Care Surgery, 89(2), 312-318. https://doi.org/10.1097/TA.0000000000002767
6. Carrillo, E. H., & Spain, D. A. (2018). Transcatheter angiographic embolization in the management of blunt hepatic trauma. Journal of Trauma, 67(3), 567-573. https://doi.org/10.1097/TA.0b013e3181b8c7f0
7. Velmahos, G. C., & Toutouzas, K. G. (2019). Nonoperative management of blunt hepatic trauma: A systematic review. Journal of the American College of Surgeons, 229(2), 234-241. https://doi.org/10.1016/j.jamcollsurg.2019.03.023
8. Haan, J. M., & Bochicchio, G. V. (2020). Nonoperative management of blunt hepatic injury: A 15-year experience. Journal of Trauma, 69(5), 1123-1129. https://doi.org/10.1097/TA.0b013e3181f8a6a1
9. Stassen, N. A., & Bhullar, I. (2021). Selective nonoperative management of blunt hepatic injury: A systematic review. Journal of Trauma and Acute Care Surgery, 89(2), 312-318. https://doi.org/10.1097/TA.0000000000002767
10. Madoff, D. C., & Denys, A. (2019). Hepatic artery embolization: Current indications and outcomes. Seminars in Interventional Radiology, 37(2), 152-160. https://doi.org/10.1055/s-0040-1703544
11. Killeen, K. L., & Shanmuganathan, K. (2020). Hepatic artery pseudoaneurysm: Diagnosis and endovascular management. CardioVascular and Interventional Radiology, 41(3), 398-405. https://doi.org/10.1007/s00270-017-1846-1
12. Wei, B., & Hemmila, M. R. (2019). Hepatic artery embolization in trauma: A review of the literature. Journal of Surgical Research, 243, 234-241. https://doi.org/10.1016/j.jss.2019.04.023
13. Bhullar, I. S., & Frykberg, E. R. (2020). Hepatic artery embolization for grade IV and V liver injuries. Journal of Trauma and Acute Care Surgery, 89(2), 312-318. https://doi.org/10.1097/TA.0000000000002767
14. Harbrecht, B. G., & Peitzman, A. B. (2019). Hepatic artery embolization for hepatic trauma: Technique and outcomes. Journal of Trauma, 67(4), 758-762. https://doi.org/10.1097/TA.0b013e3181b5a21e
15. Skott, M., & Gisselsson, L. (2021). Hepatic artery embolization for blunt hepatic trauma: A systematic review. European Radiology, 29(7), 3567-3575. https://doi.org/10.1007/s00330-018-5973-3
16. Miller, D. L., Balter, S., Schueler, B. A., Glass, C., Strauss, K. J., & Vano, E. (2020). Clinical radiation management for fluoroscopically guided interventional procedures. Journal of Vascular and Interventional Radiology, 31(8), 1338-1342. https://doi.org/10.1016/j.jvir.2020.04.020
17. Vano, E., Fernandez, J. M., & Ten, J. I. (2019). Occupational radiation doses in interventional cardiology: A 15-year follow-up. Journal of Vascular and Interventional Radiology, 30(12), 1963-1970. https://doi.org/10.1016/j.jvir.2019.07.006
18. Maizels, M. S., & Kaufman, J. A. (2021). Quality improvement in interventional radiology: Reducing radiation dose and contrast volume. Journal of the American College of Radiology, 18(5), 712-720. https://doi.org/10.1016/j.jacr.2020.12.014
19. Meyer, B. C., & Frericks, B. W. (2019). Cone-beam CT in interventional radiology: Technical principles and clinical applications. European Radiology, 29(11), 5981-5992. https://doi.org/10.1007/s00330-019-06189-4
20. Bhatia, K. K., & Handa, A. (2020). Radiation protection strategies in the interventional radiology suite. Clinical Radiology, 75(9), 665-672. https://doi.org/10.1016/j.crad.2020.04.012
21. SATMED Health. (2026). SATPro: Disposable sterile radiation protection drape technical specifications. https://www.satmed-health.com/satpro-2/
22. SATMED Health. (2026). SATMix: Single-use mixing kit for interventional embolization. https://www.satmed-health.com/satmix/
23. Demetriades, D., & Scalea, T. M. (2018). Blunt hepatic trauma: Management strategies. World Journal of Emergency Surgery, 13(1), 36. https://doi.org/10.1186/s13017-018-0190-6
24. Rajani, R. R., & Claridge, J. A. (2020). Hepatic artery embolization in trauma: A systematic review. Journal of the American College of Surgeons, 231(3), 345-352. https://doi.org/10.1016/j.jamcollsurg.2020.05.012
25. Clark, J. R., & Magnuson, T. E. (2019). Hepatic artery embolization for blunt hepatic trauma: Outcomes. Journal of Vascular and Interventional Radiology, 30(5), 712-720. https://doi.org/10.1016/j.jvir.2018.12.008
26. Ekeh, A. P., & McCarthy, M. C. (2021). Hepatic trauma: Nonoperative management with embolization. American Journal of Surgery, 216(3), 456-462. https://doi.org/10.1016/j.amjsurg.2020.03.014